Target Price | $163.00 |
Price | $149.79 |
Potential |
8.82%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target DaVita HealthCare Partners 2025 .
The average DaVita HealthCare Partners target price is $163.00.
This is
8.82%
register free of charge
$186.00
24.17%
register free of charge
$145.00
3.20%
register free of charge
|
|
A rating was issued by 11 analysts: 2 Analysts recommend DaVita HealthCare Partners to buy, 7 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2025 of
8.82%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 12.14 | 12.79 |
4.57% | 5.33% | |
EBITDA Margin | 19.33% | 20.99% |
9.72% | 8.60% | |
Net Margin | 5.05% | 6.27% |
24.27% | 24.17% |
5 Analysts have issued a sales forecast DaVita HealthCare Partners 2024 . The average DaVita HealthCare Partners sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2024. The average DaVita HealthCare Partners EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 DaVita HealthCare Partners Analysts have issued a net profit forecast 2024. The average DaVita HealthCare Partners net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 7.42 | 9.70 |
29.95% | 30.73% | |
P/E | 15.91 | |
EV/Sales | 1.99 |
3 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the DaVita HealthCare Partners stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
DaVita HealthCare Partners...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.